Electroacupuncture Exerts an Anti-migraine Effect Via Modulation of the 5-HT7 Receptor in the Conscious Rat
Overview
Affiliations
Background: Acupuncture has been recommended as an alternative therapy for migraine. Emerging evidence suggests that the 5-HT receptor (5-HTR) plays a significant facilitatory role in descending modulation in migraine pathophysiology, and that activation of 5-HTR in the descending pathway is involved in migraine central sensitisation.
Objective: To investigate the ability of electroacupuncture (EA) to ameliorate central sensitisation via modulation of 5-HTR in the descending pain pathways using a rat model of migraine induced by repetitive dural electrical stimulation (DES).
Design: 64 male Sprague-Dawley rats were randomly divided into four groups: Normal group; DES group (receiving dural electrical stimulation only); DES+GB20 group (DES model group treated with EA at GB20); and DES+Sham group (DES model group treated with EA at a non-traditional (sham) acupuncture point). The presence of cutaneous allodynia was determined by measuring facial and hind-paw withdrawal latencies to electronic von-Frey. The expression of 5-HTR in the descending pathways (periaqueductal grey, raphe magnus nucleus, and trigeminal nucleus caudalis) was assessed using immunofluorescence and Western blotting.
Results: Facial and hind-paw withdrawal thresholds were significantly increased in the DES+GB20 group compared with the untreated DES group. The expression of 5-HTR was significantly decreased in the DES+GB20 group compared with the DES group (one-way analysis of variance (ANOVA), P<0.05). No significant differences in behaviour or expression were found between the rats in the DES+Sham group and the untreated DES group (one-way ANOVA, P>0.05).
Conclusion: EA at GB20 may ameliorate central sensitisation in migraine by inhibiting the activation of 5-HT receptors in the descending pain pathway in a rat model of migraine.
The Mechanism of Acupuncture Therapy for Migraine: A Systematic Review of Animal Studies on Rats.
An Y, Zhang J, Ren Q, Liu J, Liu Z, Cao K J Pain Res. 2025; 18:473-487.
PMID: 39882184 PMC: 11776926. DOI: 10.2147/JPR.S504892.
Luo J, Feng L, Wang L, Fang Z, Lang J, Lang B Brain Circ. 2024; 10(2):154-161.
PMID: 39036293 PMC: 11259319. DOI: 10.4103/bc.bc_95_23.
Animal Models of Chronic Migraine: From the Bench to Therapy.
Zhang W, Zhang Y, Wang H, Sun X, Chen L, Zhou J Curr Pain Headache Rep. 2024; 28(11):1123-1133.
PMID: 38954246 DOI: 10.1007/s11916-024-01290-y.
Zhou M, Pang F, Liao D, Yang Y, Wang Y, Yang Z Mol Pain. 2024; 20:17448069241258113.
PMID: 38744426 PMC: 11143845. DOI: 10.1177/17448069241258113.
Ye G, Miao R, Chen J, Huang J, Jiang M J Pain Res. 2024; 17:305-319.
PMID: 38268732 PMC: 10807275. DOI: 10.2147/JPR.S439906.